Development and Content Evaluation of the Eating Behavior and Appetite Questionnaire (EBAQ) for Individuals with Obesity
The EBAQ may be used in clinical trials, clinical practice, or observational research to evaluate the impact of obesity and the effect of obesity treatment on appetite and eating behaviors.
Authors
- Hayley Karn (ORCID: https://orcid.org/0009-0009-6383-9544)
- Lisa M. Neff (ORCID: https://orcid.org/0000-0002-3006-6057)
- Chisom Kanu (ORCID: https://orcid.org/0000-0002-2621-8652)
- Claudine Clucas (ORCID: https://orcid.org/0000-0002-8196-9686)
- Kristina Secnik Boye (ORCID: https://orcid.org/0000-0002-5953-5929)
- Iris Goetz (ORCID: https://orcid.org/0000-0003-0898-9530)
- Anne Skalicky (ORCID: https://orcid.org/0000-0001-9865-3824)
- Ashley Samuelson
Institutions
- Eli Lilly (United States) (US)
- Thermo Fisher Scientific (United Kingdom) (GB)
- Thermo Fisher Scientific (Israel) (IL)
Publication Details
- Journal
- Advances in Therapy
- Published
- 2025-11-07
- DOI
- https://doi.org/10.1007/s12325-025-03386-2
- Citations
- 1
- Primary Topic
- Bariatric Surgery and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 2.01
Funders
- Eli Lilly and Company